Literature DB >> 33489350

Characteristics of Facial Asymmetry in Congenital Superior Oblique Palsy according to Trochlear Nerve Absence.

Hee Kyung Yang1, Sumin Jung2, Taeg Keun WhangBo3, Jeong-Min Hwang1.   

Abstract

METHODS: A total of 287 consecutive patients diagnosed with congenital SOP and 82 control subjects were included. Congenital SOP patients were grouped according to the presence (present group) or absence (absent group) of the trochlear nerve using thin-section high-resolution MRI of cranial nerves. We developed a computer-aided detection (CAD) system that could automatically analyze objective indices of facial asymmetry using frontal face photographs.
RESULTS: Of the 287 patients with congenital SOP, 60% of patients had ipsilateral trochlear nerve absence and superior oblique muscle (SO) hypoplasia (absent group), while the remaining 40% had a normal SO and trochlear nerve (present group). All but one objective indices related to facial asymmetry were significantly different between congenital SOP patients and controls (all P < 0.05). Among these features, the angle of nose deviation was significantly larger in the absent group compared to the present group (P < 0.001).
CONCLUSION: Objective analysis of facial asymmetry using our novel CAD system was useful for identifying distinct features of congenital SOP. Deviation of the nose was more prominent in congenital SOP patients with trochlear nerve absence.
Copyright © 2020 Hee Kyung Yang et al.

Entities:  

Year:  2020        PMID: 33489350      PMCID: PMC7803132          DOI: 10.1155/2020/9476749

Source DB:  PubMed          Journal:  J Ophthalmol        ISSN: 2090-004X            Impact factor:   1.909


  19 in total

1.  Quantitative analysis of structure-function relationship between ocular motility and superior oblique muscle hypoplasia in unilateral superior oblique palsy.

Authors:  Ji Eun Lee; Hee Kyung Yang; Jae Hyoung Kim; Jeong-Min Hwang
Journal:  Br J Ophthalmol       Date:  2018-11-08       Impact factor: 4.638

2.  High-resolution 3D MR imaging of the trochlear nerve.

Authors:  B S Choi; J H Kim; C Jung; J-M Hwang
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-21       Impact factor: 3.825

3.  Morphometry of the trochlear nerve and superior oblique muscle volume in congenital superior oblique palsy.

Authors:  Dae Seung Lee; Hee Kyung Yang; Jae Hyoung Kim; Jeong-Min Hwang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-20       Impact factor: 4.799

4.  Absence of the trochlear nerve in patients with superior oblique hypoplasia.

Authors:  Jae Hyoung Kim; Jeong-Min Hwang
Journal:  Ophthalmology       Date:  2010-06-08       Impact factor: 12.079

5.  Congenital superior oblique palsy and trochlear nerve absence: a clinical and radiological study.

Authors:  Hee Kyung Yang; Jae Hyoung Kim; Jeong-Min Hwang
Journal:  Ophthalmology       Date:  2011-09-15       Impact factor: 12.079

6.  Cephalometric interpretation and assessment of facial asymmetry secondary to congenital torticollis. The significance of cranial base reference lines.

Authors:  J W Ferguson
Journal:  Int J Oral Maxillofac Surg       Date:  1993-02       Impact factor: 2.789

7.  Association of superior oblique muscle volumes with the presence or absence of the trochlear nerve on high-resolution MR imaging in congenital superior oblique palsy.

Authors:  H K Yang; D S Lee; J H Kim; J-M Hwang
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-02       Impact factor: 3.825

8.  Surgical treatment of superior oblique palsy.

Authors:  E M Helveston; J S Mora; S N Lipsky; D A Plager; F D Ellis; D T Sprunger; N Sondhi
Journal:  Trans Am Ophthalmol Soc       Date:  1996

9.  Amblyopia & Strabismus Questionnaire: design and initial validation.

Authors:  E S van de Graaf; G W van der Sterre; J R Polling; H van Kempen; B Simonsz; H J Simonsz
Journal:  Strabismus       Date:  2004-09

10.  Facial asymmetry and tendon laxity in superior oblique palsy.

Authors:  E A Paysee; D K Coats; D A Plager
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1995 May-Jun       Impact factor: 1.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.